Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings

Funding Agency:
Centers for Disease Control and Prevention

The purpose of this NOFO is to support comparative effectiveness trials to investigate the feasibility, effectiveness, and cost-effectiveness of telehealth-based interventions to detect and manage glaucoma among high-risk populations. This NOFO aims to support the study of replicable and scalable interventions that use real-world, payer-provider reimbursement structures within community-based, health care delivery settings in various regions of the United States. Outcomes should be relevant to clinical practice, public health, community implementation, and policy. This NOFO also supports the cost-effectiveness analyses of proposed interventions. The resulting data will assist policymakers, clinicians, and patients make informed decisions to reduce the burden of glaucoma and improve the quality of life for millions of people.

This NOFO will be accomplished through two components, Component A: Comparative effectiveness trials among high-risk populations within community-based settings, and Component B: a coordinating center to provide scientific and logistical support to Component A studies.

Only one application per institution is allowed, as indicated by a unique entity identifier (UEI) at the time of submission. An organization may apply for Component A or Component B, not both. Interested applicants from within Duke should contact fundopps@duke.edu as early as possible.

Deadline: Feb. 5, 2024

Agency Website

Funding Type





Community Outreach and Engagement
Medical - Clinical Science
Medical - Translational

External Deadline

February 5, 2024